DMRTA1 Inhibitors
Chemical inhibitors of DMRTA1 can play a role in modulating its function through various biochemical pathways. SB-431542, a selective inhibitor of the TGF-β receptor ALK5, can disrupt the TGF-β signaling pathway which is important for neural differentiation where DMRTA1 is involved. The inhibition of ALK5 by SB-431542 would lead to a decrease in TGF-β signaling, a pathway that could be critical for DMRTA1's role in neurogenesis. Similarly, LY294002, by inhibiting phosphoinositide 3-kinases (PI3K), can lead to a reduction in downstream signaling events necessary for DMRTA1's involvement in neuronal development. PI3K pathways are crucial for a range of cellular processes, including those related to the activity of DMRTA1. U0126 and PD98059, both inhibitors of MEK1/2, can suppress the MAPK/ERK pathway, which is implicated in cell growth and differentiation. Since DMRTA1 is implicated in brain development, the inhibition of this pathway by U0126 or PD98059 can lead to an indirect functional inhibition of DMRTA1.
Further, XAV-939 can inhibit the Wnt signaling pathway by stabilizing axin and preventing β-catenin mediated transcription, which could influence the cellular processes involving DMRTA1. The γ-secretase inhibitor DAPT can prevent Notch signaling, which is involved in the differentiation of neural cells, a process where DMRTA1 is also active. The action of DAPT could thus indirectly affect DMRTA1's function. SU5402's role as a fibroblast growth factor receptor (FGFR) inhibitor can alter the FGFR signaling that influences neural development, indirectly affecting DMRTA1. Indirubin-3'-monoxime's inhibition of cyclin-dependent kinases (CDKs) and GSK-3β can interfere with cell cycle regulation and neurogenesis, thereby inhibiting cellular processes critical to DMRTA1's function. SP600125, through its inhibition of c-Jun N-terminal kinase (JNK), can disrupt stress-activated pathways that influence cell differentiation, which may involve DMRTA1. BIX 02189 selectively inhibits MEK5, which is part of the ERK5 pathway; this disruption can affect the neurogenesis processes involving DMRTA1. Y-27632 inhibits the Rho-associated kinase (ROCK), which can impact cellular structure and motility, processes important for DMRTA1's role in neural differentiation. Lastly, Go6976, as a protein kinase C (PKC) inhibitor, can disrupt signaling pathways that regulate cell differentiation, thereby influencing the activity of DMRTA1 in such processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 is a selective inhibitor of the TGF-β receptor type I, ALK5. DMRTA1 is involved in neurogenesis and could be influenced by the TGF-β signaling pathway. By inhibiting this receptor, SB-431542 can prevent signaling that may be necessary for DMRTA1 to exert its effects on neural differentiation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of phosphoinositide 3-kinases (PI3K), which are involved in various signaling pathways, including those that might impact neurogenesis and differentiation where DMRTA1 is relevant. Inhibition of PI3K can lead to a reduction in the activity of downstream effectors that could be required for DMRTA1 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is another MEK inhibitor that works by blocking the activation of MEK1/2. Since DMRTA1 is involved in brain development, inhibiting MEK can disrupt the MAPK/ERK pathway's role in this process, thereby functionally inhibiting DMRTA1 activity in neural cells. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV-939 is a Wnt pathway inhibitor that specifically inhibits tankyrases, leading to stabilization of axin and inhibition of β-catenin mediated transcription. DMRTA1, with a role in neurodevelopment, could be influenced by Wnt signaling, and inhibition of this pathway could thus hinder DMRTA1's function in cellular differentiation. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT is a γ-secretase inhibitor that can prevent the cleavage of proteins such as Notch, which are involved in cell differentiation. Given that DMRTA1 is involved in neural differentiation, inhibition of Notch signaling by DAPT can indirectly inhibit the functional processes where DMRTA1 is active. | ||||||
SU 5402 | 215543-92-3 | sc-204308 sc-204308A | 1 mg 5 mg | $63.00 $98.00 | 36 | |
SU5402 is a potent inhibitor of fibroblast growth factor receptor (FGFR). FGFR signaling can influence neural development, and by inhibiting this receptor, SU5402 can indirectly alter the cellular environment and processes where DMRTA1 is functional. | ||||||
Indirubin-3′-monoxime | 160807-49-8 | sc-202660 sc-202660A sc-202660B | 1 mg 5 mg 50 mg | $79.00 $321.00 $671.00 | 1 | |
Indirubin-3'-monoxime is a known inhibitor of cyclin-dependent kinases (CDKs) and GSK-3β. By inhibiting CDKs, this compound can affect cell cycle regulation and neurogenesis, pathways that are critical to DMRTA1's function in brain development. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is part of stress-activated pathways and can influence cellular differentiation and apoptosis. Inhibition of JNK could affect the signaling pathways and cellular contexts necessary for DMRTA1 function. | ||||||
BIX 02189 | 1094614-85-3 | sc-364436 sc-364436A | 5 mg 10 mg | $224.00 $386.00 | 5 | |
BIX 02189 is a selective inhibitor of MEK5, a kinase involved in the ERK5 pathway. Since DMRTA1 is implicated in neurogenesis, disrupting the MEK5/ERK5 pathway can inhibit the cellular processes that DMRTA1 influences in brain development. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of the Rho-associated kinase (ROCK). ROCK signaling influences cellular structure and motility, which can affect neurogenesis and the neural differentiation processes that involve DMRTA1. | ||||||